Document is current
Any future updates will be listed below
-
Authors
Held, Thomas https://orcid.org/0000-0002-3913-4693
Herpel, Christopher
Schwindling, Franz Sebastian
Christ, Leo
Lang, Kristin
Regnery, Sebastian
Eichkorn, Tanja
Hommertgen, Adriane
Jaekel, Cornelia
Krisam, Johannes
Moratin, Julius
Mrosek, Jan
Metzger, Karl
Zaoui, Karim
Moutsis, Tracy
Harrabi, Semi
Herfarth, Klaus
Freudlsperger, Christian
Rammelsberg, Peter
Debus, Jürgen
Adeberg, Sebastian
-
Funding
Funding for this research was provided by:
Nationales Centrum für Tumorerkrankungen Heidelberg
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 5 January 2021
Accepted: 7 April 2021
First Online: 17 April 2021
Declarations
:
: The Ethics Committee of the medical faculty of Heidelberg University approved this study on June 8th, 2020 (S-394/2020).
: Not applicable.
: S.A. received grants from Novocure Inc., Accuray International Sàrl and Merck Serono GmbH outside the submitted work. J.D. received grants from CRI–The Clinical Research Institute GmbH, View Ray Inc., Accuray International Sàrl, Accuray Incorporated, RaySearch Laboratories AB, Vision RT limited, Merck Serono GmbH, Astellas Pharma GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutical Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix A.A. outside the submitted work. The other authors declare no conflict of interest.
